(MedPage Today) -- Is there a "best” way to switch patients after anti-tumor necrosis therapy failure? The answer to that question will create buzz this week. The third Systemic Sclerosis World Congress should also garner headlines. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment